Search - tctmd.com

Displaying 321 - 340 of 881

Sort: Relevancy | Date

News Daily News

Post-TAVR Aspirin Monotherapy No Less Effective, Possibly Safer Than DAPT

May 14, 2015

News Daily News

La Monoterapia con Aspirina Post-TAVR No es Menos Eficaz y es Posiblemente Más Segura que el Tratamiento Antiplaquetario Doble

May 14, 2015

News Industry News

Knowledge Gaps and Misperceptions on Impact of Atrial Fibrillation and Stroke Exist Among Patients, Caregivers and Physicians

May 13, 2015

News Industry News

Medtronic Receives FDA Approval and CE Mark for Arctic Front Advance® ST Cryoballoon to Treat Atrial Fibrillation

May 12, 2015

News Industry News

Boston Scientific Announces Scheduled Presentations at Heart Rhythm Society 2015

May 11, 2015

News Daily News

A-fib Identified as a Risk Factor for Incident NSTEMI

Todd Neale

May 07, 2015

News Industry News

Medtronic Initiates Study of 'In-Office' Insertion of Reveal LINQ(TM) Cardiac Monitor

May 07, 2015

Presentation

A-fib and Risk of STEMI vs NSTEMI

Presenter: Elsayed Z. Soliman

May 06, 2015

News Daily News

Post-TAVR Thrombus May Be More Common Than Thought, Often Subclinical

L.A. McKeown

May 06, 2015

News Daily News

Real-World Studies Highlight GI Bleeding Concerns With Newer Anticoagulants

L.A. McKeown

May 04, 2015

News Daily News

Silent A-fib After Acute MI Portends Poor Outcome

Yael L. Maxwell

May 01, 2015

Presentation

Prognosis of Silent A-fib After Acute MI at 1 Year

Presenter: K. Stamboul

April 30, 2015

News Daily News

Study Provides Insight Into Cerebral Embolization During TAVR

April 29, 2015

News Daily News

Length of Time Between Staged PCI, TAVR Minimally Affects Short-term Outcomes

Yael L. Maxwell

April 29, 2015

News Daily News

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

April 29, 2015

News Daily News

Una Gran Minoría de Pacientes con Fibrilación Auricular de Bajo Riesgo Siguen Recibiendo Anticoagulantes

Salynn Boyles

April 28, 2015

News Daily News

Substantial Minority of Low-Risk A-fib Patients Still Given Anticoagulants

Salynn Boyles

April 28, 2015

News Daily News

Registry Finds No Stark Differences Between Proximal, Distal Embolic Protection in CAS

Caitlin E. Cox

April 28, 2015

Presentation ECHO 2015

Transesophageal Echocardiography For Clinical Decision Making In Stroke and Atrial Fibrillation

Presenter: Fletcher A. Miller

April 26, 2015

Presentation

Oral Anticoagulant Prescription in Patients With A-fib and Low Risk of Thromboembolism

Presenter: J.C. Hsu

April 23, 2015

Advertisement

Post-TAVR Aspirin Monotherapy No Less Effective, Possibly Safer Than DAPT

La Monoterapia con Aspirina Post-TAVR No es Menos Eficaz y es Posiblemente Más Segura que el Tratamiento Antiplaquetario Doble

Knowledge Gaps and Misperceptions on Impact of Atrial Fibrillation and Stroke Exist Among Patients, Caregivers and Physicians

Medtronic Receives FDA Approval and CE Mark for Arctic Front Advance® ST Cryoballoon to Treat Atrial Fibrillation

Boston Scientific Announces Scheduled Presentations at Heart Rhythm Society 2015

A-fib Identified as a Risk Factor for Incident NSTEMI

Medtronic Initiates Study of 'In-Office' Insertion of Reveal LINQ(TM) Cardiac Monitor

A-fib and Risk of STEMI vs NSTEMI

Post-TAVR Thrombus May Be More Common Than Thought, Often Subclinical

Real-World Studies Highlight GI Bleeding Concerns With Newer Anticoagulants

Silent A-fib After Acute MI Portends Poor Outcome

Prognosis of Silent A-fib After Acute MI at 1 Year

Study Provides Insight Into Cerebral Embolization During TAVR

Length of Time Between Staged PCI, TAVR Minimally Affects Short-term Outcomes

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

Una Gran Minoría de Pacientes con Fibrilación Auricular de Bajo Riesgo Siguen Recibiendo Anticoagulantes

Substantial Minority of Low-Risk A-fib Patients Still Given Anticoagulants

Registry Finds No Stark Differences Between Proximal, Distal Embolic Protection in CAS

Transesophageal Echocardiography For Clinical Decision Making In Stroke and Atrial Fibrillation

Oral Anticoagulant Prescription in Patients With A-fib and Low Risk of Thromboembolism

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content